Soft Lens Study: Biomedics 1 Day Extra Sphere and Clariti 1 Day Sphere
NCT ID: NCT06817785
Last Updated: 2025-02-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
50 participants
INTERVENTIONAL
2025-01-24
2025-02-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Investigation of Proclear® 1 Day and MyDay® Sphere Contact Lenses
NCT07104773
Short-term Study of Two Soft Contact Lenses in Wearers With Low Astigmatism
NCT06873048
Comparative Study of Two Marketed 1-day Soft Contact Lenses
NCT01464255
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
NCT06869044
Clinical Evaluation of Proclear Toric and Biofinity Toric
NCT06431061
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lens 1 (ocufilcon D)
All participants will wear lens 1 for 15 minutes (Period 1).
Lens 1 (ocufilcon D)
15 minutes of daily wear
Lens 2 (somofilcon A)
All participants will wear lens 2 for 15 minutes (Period 2).
Lens 2 (somofilcon A)
15 minutes of daily wear
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lens 1 (ocufilcon D)
15 minutes of daily wear
Lens 2 (somofilcon A)
15 minutes of daily wear
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Have understood and signed an information consent letter;
3. Are willing and able to maintain the appointment schedule;
4. Are an adapted soft contact lens wearer;
5. Have a vertex-corrected contact lens prescription of -1.00DS to -6.00DS (inclusive) in each eye;
6. Have a refraction with a cylinder component of no more than -1.00DC in each eye;
7. Can be fitted with and achieve a distance visual acuity of +0.10 logMAR or better in each eye with the study contact lenses.
Exclusion Criteria
2. Have any known active ocular disease and/or infection or slit lamp findings that would contraindicate contact lens use;
3. Have a systemic condition that would contraindicate contact lens use;
4. Are using any systemic or topical medications that would contraindicate contact lens use;
5. Have known sensitivity to the diagnostic fluorescein sodium to be used in the study;
6. Are an employee of the Centre for Ocular Research \& Education directly involved in the study (i.e. on the delegation log).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre for Ocular Research & Education, Canada
OTHER
CooperVision International Limited (CVIL)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lyndon Jones, PhD FCOptom
Role: PRINCIPAL_INVESTIGATOR
Centre for Ocular Research and Education
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Optometry and Vision Science
Waterloo, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EX-MKTG-164
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.